<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36807719</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2151-4658</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Arthritis care &amp; research</Title><ISOAbbreviation>Arthritis Care Res (Hoboken)</ISOAbbreviation></Journal><ArticleTitle>Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review.</ArticleTitle><Pagination><StartPage>2054</StartPage><EndPage>2062</EndPage><MedlinePgn>2054-2062</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acr.25106</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Clinical visits are a fundamental aspect of rheumatic disease care, but recommendations for appropriate visit frequencies are largely absent from guidelines, scarcely studied, and inconsistently reported. The aim of this systematic review was to summarize the evidence pertaining to visit frequencies for major rheumatic diseases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Title/abstract screening, full-text screening, and extraction were carried out by 2 independent authors. Annual visit frequencies were either extracted or calculated and stratified by disease type and country of study. Weighted mean annual visit frequencies were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 273 relevant manuscript records were screened, and 28 were included after applying selection criteria. The included studies were equally divided between US and non-US and were published between 1985 and 2021. Most (n&#xa0;=&#xa0;16) focused on rheumatoid arthritis (RA), systemic lupus erythematosus (SLE; n&#xa0;=&#xa0;5), and fibromyalgia (FM; n&#xa0;=&#xa0;4). For RA, the average annual visit frequencies were 5.25 for US rheumatologists, 4.80 for US non-rheumatologists, 3.29 for non-US rheumatologists, and 2.74 for non-US non-rheumatologists. For SLE, annual visit frequencies for non-rheumatologists were much higher than for US rheumatologists (12.3 versus 3.24). For FM, annual visit frequencies were 1.80 for US rheumatologists and 0.40 for non-US rheumatologists. There was a decreasing trend of visit frequency to rheumatologists from 1982 to 2019.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Evidence for rheumatology clinical visits was limited and heterogeneous on a global scale. However, general trends suggest more frequent visits in the US and less frequent visits in recent years.</AbstractText><CopyrightInformation>&#xa9; 2023 American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yuxuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7650-326X</Identifier><AffiliationInfo><Affiliation>McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudin</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>RAND Corporation, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0001-8202-5428</Identifier><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AR072577</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AR-P30-072577</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Care Res (Hoboken)</MedlineTA><NlmUniqueID>101518086</NlmUniqueID><ISSNLinking>2151-464X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072140" MajorTopicYN="N">Rheumatologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>12</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36807719</ArticleId><ArticleId IdType="mid">NIHMS1876149</ArticleId><ArticleId IdType="pmc">PMC10440366</ArticleId><ArticleId IdType="doi">10.1002/acr.25106</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>What is a Rheumatologist?
Accessed
August 14, 2022. https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Health-Care-Team/What-is-a-Rheumatologist</Citation></Reference><Reference><Citation>Duncan R, Cheng L, Law MR, Shojania K, De Vera MA, Harrison M. The impact of introducing multidisciplinary care assessments on access to rheumatology care in British Columbia: an interrupted time series analysis. BMC Health Serv Res. 2022;22:327. doi:10.1186/s12913-022-07715-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-07715-x</ArticleId><ArticleId IdType="pmc">PMC8915460</ArticleId><ArticleId IdType="pubmed">35277162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguli I, Wasfy JH, Ferris TG. What is the right number of clinic appointments?: Visit frequency and the accountable care organization. JAMA. 2015;313(19):1905&#x2013;1906. doi:10.1001/jama.2015.3356</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3356</ArticleId><ArticleId IdType="pubmed">25844726</ArticleId></ArticleIdList></Reference><Reference><Citation>National Guideline Centre (UK). Frequency of Monitoring: Rheumatoid Arthritis in Adults: Diagnosis and Management: Evidence Review E. National Institute for Health and Care Excellence (NICE); 2018. Accessed
August 14, 2022. http://www.ncbi.nlm.nih.gov/books/NBK577121/</Citation><ArticleIdList><ArticleId IdType="pubmed">35129929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149&#x2013;162. doi:10.1002/acr.24131</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24131</ArticleId><ArticleId IdType="pubmed">31908149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward MM. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. The Journal of rheumatology. 1997;24(1):35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9002008</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggenborg RP, Madsen OR, Dreyer L, Bukh G, Hansen A. Patient-controlled outpatient follow-up on demand for patients with rheumatoid arthritis: a 2-year randomized controlled trial. Clinical rheumatology. 2021;40(9):3599&#x2013;3604. doi:10.1007/s10067-021-05674-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05674-y</ArticleId><ArticleId IdType="pmc">PMC7936865</ArticleId><ArticleId IdType="pubmed">33677724</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough JD, Patel K, Shrank WH. Variation in Specialty Outpatient Care Patterns in the Medicare Population. J Gen Intern Med. 2016;31(11):1278&#x2013;1286. doi:10.1007/s11606-016-3745-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-016-3745-8</ArticleId><ArticleId IdType="pmc">PMC5071277</ArticleId><ArticleId IdType="pubmed">27259290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachrison KS, Yan Z, Schwamm LH. Changes in Virtual and In-Person Health Care Utilization in a Large Health System During the COVID-19 Pandemic. JAMA Network Open. 2021;4(10):e2129973. doi:10.1001/jamanetworkopen.2021.29973</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.29973</ArticleId><ArticleId IdType="pmc">PMC8552053</ArticleId><ArticleId IdType="pubmed">34705016</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Maini M, Adelowo F, Al Saleh J, et al. The global challenges and opportunities in the practice of rheumatology: White paper by the World Forum on Rheumatic and Musculoskeletal Diseases. Clin Rheumatol. 2015;34(5):819&#x2013;829. doi:10.1007/s10067-014-2841-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2841-6</ArticleId><ArticleId IdType="pmc">PMC4408363</ArticleId><ArticleId IdType="pubmed">25501633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale MeSH Analyzer. Accessed
August 14, 2022. https://mesh.med.yale.edu/</Citation></Reference><Reference><Citation>Gendelman O, Shapira R, Tiosano S, et al. Utilisation of healthcare services and drug consumption in fibromyalgia: A cross-sectional analysis of the Clalit Health Service database. International journal of clinical practice. 2021;(cvt, 9712381):e14729. doi:10.1111/ijcp.14729</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14729</ArticleId><ArticleId IdType="pubmed">34383362</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelmann A, Perrot S, Schaefer C, et al. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Applied health economics and health policy. 2011;9(2):125&#x2013;136. doi:10.2165/11535250-000000000-00000</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11535250-000000000-00000</ArticleId><ArticleId IdType="pubmed">21332254</ArticleId></ArticleIdList></Reference><Reference><Citation>World Bank Country and Lending Groups &#x2013; World Bank Data Help Desk. Accessed
August 14, 2022. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups</Citation></Reference><Reference><Citation>Hogan PF, Bouchery E. Workfoce Study of Rheumatologists - Final Report. American College of Rheumatologists; 2006. https://www.rheumatology.org/Portals/0/Files/LewinReport.pdf</Citation></Reference><Reference><Citation>Df B, M D, Mb B, et al. 2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015&#x2013;2030. Arthritis care &amp; research. 2018;70(4). doi:10.1002/acr.23518</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.23518</ArticleId><ArticleId IdType="pubmed">29400009</ArticleId></ArticleIdList></Reference><Reference><Citation>A survey of the New Zealand rheumatology workforce - PubMed. Accessed
October 3, 2022. https://pubmed.ncbi.nlm.nih.gov/31830019/</Citation></Reference><Reference><Citation>Lee CU, Kim JN, Kim JW, et al. Korean rheumatology workforce from 1992 to 2015: current status and future demand. Korean J Intern Med. 2019;34(3):660&#x2013;668. doi:10.3904/kjim.2016.417</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2016.417</ArticleId><ArticleId IdType="pmc">PMC6506748</ArticleId><ArticleId IdType="pubmed">29232941</ArticleId></ArticleIdList></Reference><Reference><Citation>Miedema HS, van der Linden SM, Rasker JJ, Valkenburg HA. National database of patients visiting rheumatologists in The Netherlands: the standard diagnosis register of rheumatic diseases. A report and preliminary analysis. Br J Rheumatol. 1998;37(5):555&#x2013;561. doi:10.1093/rheumatology/37.5.555</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/37.5.555</ArticleId><ArticleId IdType="pubmed">9651085</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis - PubMed. Accessed
October 3, 2022. https://pubmed.ncbi.nlm.nih.gov/34101387/</Citation></Reference><Reference><Citation>Smolen JS, Landew&#xe9; RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. 2020;79(6):685&#x2013;699. doi:10.1136/annrheumdis-2019-216655</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216655</ArticleId><ArticleId IdType="pubmed">31969328</ArticleId></ArticleIdList></Reference><Reference><Citation>Case JP. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther. 2001;8(2):123&#x2013;143. doi:10.1097/00045391-200103000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00045391-200103000-00007</ArticleId><ArticleId IdType="pubmed">11304666</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlensiepen F, May S, Zarbl J, et al. At-home blood self-sampling in rheumatology: a qualitative study with patients and health care professionals. BMC Health Serv Res. 2022;22(1):1&#x2013;11. doi:10.1186/s12913-022-08787-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08787-5</ArticleId><ArticleId IdType="pmc">PMC9718468</ArticleId><ArticleId IdType="pubmed">36461025</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe4;re P, Nikiphorou E, Hannonen P, Sokka T. Delivering a one-stop, integrated, and patient-centered service for patients with rheumatic diseases. SAGE Open Med. 2016;4:2050312116654404. doi:10.1177/2050312116654404</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050312116654404</ArticleId><ArticleId IdType="pmc">PMC4941123</ArticleId><ArticleId IdType="pubmed">27437101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin EH, Henke CJ, Kramer JS, Nevitt MC, Shearn M, Epstein WV. A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices. The New England journal of medicine. 1985;312(15):962&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">3974686</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin EH, Criswell LA, Feigenbaum PG. Health care utilization and outcomes among persons with rheumatoid arthritis in fee-for-service and prepaid group practice settings. JAMA. 1996;276(13):1048&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pubmed">8847766</ArticleId></ArticleIdList></Reference><Reference><Citation>Criswell LA, Such CL, Neuhaus JM, Yelin EH. Variation among rheumatologists in clinical outcomes and frequency of office visits for rheumatoid arthritis. The Journal of rheumatology. 1997;24(7):1266&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228122</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JN, Barrett J, Liang MH, Kaplan H, Roberts WN, Baron JA. Utilization of rheumatology physician services by the elderly. The American journal of medicine. 1998;105(4):312&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">9809693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?. Arthritis and rheumatism. 2001;44(7):1504&#x2013;1514.</Citation><ArticleIdList><ArticleId IdType="pubmed">11465700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. The Journal of rheumatology. 2002;29(6):1147&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pubmed">12064827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels CM, Kind AJH, Everett C, Mell M, McBride P, Smith M. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis. Arthritis and rheumatism. 2011;63(5):1221&#x2013;1230. doi:10.1002/art.30239</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.30239</ArticleId><ArticleId IdType="pmc">PMC3086993</ArticleId><ArticleId IdType="pubmed">21305507</ArticleId></ArticleIdList></Reference><Reference><Citation>Accortt NA, Schenfeld J, Chang E, Papoyan E, Broder MS. Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis. Advances in therapy. 2017;34(9):2093&#x2013;2103. doi:10.1007/s12325-017-0596-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-017-0596-6</ArticleId><ArticleId IdType="pmc">PMC5599457</ArticleId><ArticleId IdType="pubmed">28770517</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan G, Goh F, Hodgson T, et al. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital. The New Zealand medical journal. 2008;121(1274):34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">18535644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagel S, Petersson IF, Bremander A, Lindqvist E, Bergknut C, Englund M. Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population. Annals of the rheumatic diseases. 2013;72(7):1212&#x2013;1216. doi:10.1136/annrheumdis-2012-202571</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202571</ArticleId><ArticleId IdType="pubmed">23223424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson K, Jacobsson LTH, Rydberg B, et al. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. BMC musculoskeletal disorders. 2016;17(1):499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5154076</ArticleId><ArticleId IdType="pubmed">27955647</ArticleId></ArticleIdList></Reference><Reference><Citation>McBain H, Shipley M, Olaleye A, Moore S, Newman S. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: a randomised controlled trial. Annals of the rheumatic diseases. 2016;75(7):1343&#x2013;1349. doi:10.1136/annrheumdis-2015-207768</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-207768</ArticleId><ArticleId IdType="pubmed">26290587</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnabe C, Jones CA, Bernatsky S, et al. Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non-First Nations Populations of Alberta, Canada. Arthritis care &amp; research. 2017;69(4):467&#x2013;474. doi:10.1002/acr.22959</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22959</ArticleId><ArticleId IdType="pubmed">27333120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Ahn E, Lee S, et al. Changing Patterns of Medical Visits and Factors Associated with No-show in Patients with Rheumatoid Arthritis during COVID-19 Pandemic. Journal of Korean medical science. 2020;35(48):e423. doi:10.3346/jkms.2020.35.e423</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e423</ArticleId><ArticleId IdType="pmc">PMC7735912</ArticleId><ArticleId IdType="pubmed">33316859</ArticleId></ArticleIdList></Reference><Reference><Citation>Muskens WD, Rongen-van Dartel SAA, Vogel C, Huis A, Adang EMM, van Riel PLCM. Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization. Rheumatology advances in practice. 2021;5(1):rkaa079. doi:10.1093/rap/rkaa079</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rap/rkaa079</ArticleId><ArticleId IdType="pmc">PMC7928564</ArticleId><ArticleId IdType="pubmed">33688619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE. Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthritis and rheumatism. 2005;53(3):395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">15934100</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina MJ, Mayor AM, Franco AE, Morell CA, Lopez MA, Vila LM. Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico. Ethnicity &amp; disease. 2008;18(2 Suppl 2):S2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735395</ArticleId><ArticleId IdType="pubmed">18646350</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian LJ, Yelin E, Yazdany J, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis and rheumatism. 2009;61(2):240&#x2013;246. doi:10.1002/art.24236</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24236</ArticleId><ArticleId IdType="pmc">PMC2875189</ArticleId><ArticleId IdType="pubmed">19177526</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh JA, Sarkin A, Shieh M, et al. Health care utilization in patients with gout. Seminars in arthritis and rheumatism. 2011;40(6):501&#x2013;511. doi:10.1016/j.semarthrit.2010.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2010.07.001</ArticleId><ArticleId IdType="pmc">PMC3026897</ArticleId><ArticleId IdType="pubmed">20828793</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran A, Schaefer C, Ryan K, Baik R, McNett M, Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. Journal of managed care pharmacy&#x202f;: JMCP. 2012;18(6):415&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10438185</ArticleId><ArticleId IdType="pubmed">22839682</ArticleId></ArticleIdList></Reference><Reference><Citation>Badley EM, Canizares M, Gunz AC, Davis AM. Visits to rheumatologists for arthritis: the role of access to primary care physicians, geographic availability of rheumatologists, and socioeconomic status. Arthritis care &amp; research. 2015;67(2):230&#x2013;239. doi:10.1002/acr.22413</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22413</ArticleId><ArticleId IdType="pubmed">25048206</ArticleId></ArticleIdList></Reference><Reference><Citation>Elek P, Varadi B, Varga M. Effects of Geographical Accessibility on the Use of Outpatient Care Services: Quasi-Experimental Evidence from Panel Count Data. Health economics. 2015;24(9):1131&#x2013;1146. doi:10.1002/hec.3201</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.3201</ArticleId><ArticleId IdType="pubmed">25989226</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres M, Sivera F, Perez-Vicente S, Vela P, Carmona L, EMAR II study group. Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis. Rheumatology international. 2016;36(11):1515&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pubmed">27498017</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent F, Bond M, Cavallaro E, et al. Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001&#x2013;2017). Vascular medicine (London, England). 2020;25(2):150&#x2013;156. doi:10.1177/1358863X19886074</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X19886074</ArticleId><ArticleId IdType="pubmed">31804152</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>